Fundamental data, methods and goals of present research on the treatment of leprosy.
D000818:Animals; D000830:Animals, Laboratory; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000494:pharmacology; D003622:Dapsone / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D009167:Mycobacterium lepraemurium / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology
D000995:Antitubercular Agents; D013449:Sulfonamides; D003622:Dapsone; D014295:Trimethoprim; D002991:Clofazimine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin